Thus, given the potential of ct‐CD45 to serve as a prognostic and/or therapeutic marker, it would be interesting to analyze changes in ct‐CD45 levels of RA and SLE patients before and after treatment with immunosuppressive drugs such as methotrexate or azathioprine. This evidence concerns the gene PTPRC and rheumatoid arthritis.